Skip to main content
Caplight Logo









SkylineDx

SkylineDx

Private
RotterdamHealthcare & Life Scienceshttps://www.skylinedx.com/

Last Round

Grant

Dec 11, 2023

Company Overview

SkylineDx is a biotechnology company that develops and commercializes gene signature-based diagnostic tests to assist healthcare professionals in personalized treatment decision-making.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Healthcare Analytics, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

molecular diagnosticsoncology diagnosticsgenomic testingmelanoma testgene expression profilingpredictive algorithmsdiagnostic AIpersonalized medicinemultiple myeloma testcancer genomicsclinical decision supportrisk stratificationlab developed testLDTbiomarker discoveryCAP/CLIA labtranslational medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SkylineDx Comparables

Compare SkylineDx with similar companies based on industry and business-model similarity.

SkylineDx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AMLo Biosciences
84%
NeraCare
80%
Castle Biosciences, Inc.
79%

SkylineDx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 11, 2023
VC RoundDec 21, 2021
VC RoundSep 2, 2019
GrantOct 4, 2016

SkylineDx Investors

Notable investors and investment history

SkylineDx investors
InvestorRounds
European CommissionGrant
Novalis LifeSciencesVC Round
VIBGrant
Stichting Van Herk InvestmentsVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 16, 2025

    Monthly visitors increased 74% MoM.

  • Dec 11, 2023

    Received grant from VIB Grand Challenges Program.

SkylineDx Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

SkylineDx Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SkylineDx's valuation, stock price, and market status.

Firmographic Details

HeadquartersRotterdam
Employee Range78
Year Founded2013
Last FundingDec 11, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?